Skip to content

Musical Intervention in Non-invasive Ventilation

Musical Intervention in the ICU: Effect on Tolerance and Acceptance of Non-invasive Ventilation

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02265458
Acronym
Mus-IRA
Enrollment
114
Registered
2014-10-16
Start date
2015-05-31
Completion date
2017-01-31
Last updated
2018-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Respiratory Failure

Keywords

Respiratory failure, NIV, Musical intervention

Brief summary

Non-invasive ventilation (NIV) might be associated with anxiety, thus leading to NIV failure, and intubation. Music therapy has been used in various clinical context, including in ICU patients under mechanical ventilation. We aim to evaluate the effect of a musical intervention on respiratory comfort during NIV for acute respiratory failure.

Detailed description

We plan a randomized controlled trial with 3 different arms, in ICU patients requiring NIV for acute respiratory failure : usual care, sensory isolation and sensory isolation and musical intervention.At the onset of respiratory failure, each patient will be randomized in one of the 3 arms. Usual care assigned patients will receive NIV according to each unit protocol; sensory isolation assigned patients will receive NIV associated with a mask obscuring the eyes and a noise-reducing headset.musical intervention patients will receive a 30 minutes musical intervention during each NIV session. Respiratory discomfort will be blindly assessed before, immediately after NIV is correctly set (5 minutes), at 30 minutes, and at hours 1, 2, 3, 4, 6, 8, 12, 16, 20, 24 according to NIV session length, and at the end of NIV session during each NIV session.

Interventions

BEHAVIORALMusical intervention and sensory isolation

30 minutes musical intervention during NIV will be administrated, along with sensory isolation (mask obscuring the eyes)

Sponsors

Assistance Publique - Hôpitaux de Paris
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* respiratory distress requiring NIV * Glasgow coma score above 12

Exclusion criteria

* NIV contraindication : Hemodynamic failure, neurologic failure, head trauma, vomiting * Severe hypoacusis people without hearing device * Decision to limit active treatment with an estimated life expectancy of less than 48 hours

Design outcomes

Primary

MeasureTime frameDescription
Variation of respiratory discomfort during the 30 first minutes of NIV30 minutesMeasure of respiratory discomfort at the beginning and the end of the first NIV session, with an analogic visual scale.

Secondary

MeasureTime frameDescription
Number of NIV failureparticipants will be followed for the duration of hospital stay or maximum 28 daysNIV failure
Quality of life3 monthsQuestionnaire
Evolution of respiratory parametersparticipants will be followed for the duration of hospital stay or maximum 28 daysMeasure of respiratory rate
Post traumatic stress disorder3 monthsquestionnaire
overall assessment of NIV (in terms of discomfort, satisfaction, and trauma)3 monthsQuestionnaire (scale)
Evolution of cardiovascular parametersparticipants will be followed for the duration of hospital stay or maximum 28 daysMeasure of heart rate

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 1, 2026